Literature DB >> 17784933

Thyroid hormone abnormalities and outcome in dogs with non-thyroidal illness.

C T Mooney1, R E Shiel, R M Dixon.   

Abstract

OBJECTIVES: To document thyroid hormone abnormalities in dogs with non-thyroidal illness and identify markers of prognostic value.
METHODS: Circulating total and free thyroxine, total triiodothyronine and thyrotropin concentrations were measured in 196 dogs with non-thyroidal illness. Clinical signs, previous medications and outcome were recorded in each case. Data were analysed to determine endocrine prognostic factors, and to document the prevalence of thyroid hormone abnormalities.
RESULTS: Total triiodothyronine, and total and free thyroxine concentrations were decreased in 75.9, 34.7 and 4.5 per cent of cases, respectively. Dogs which were euthanased had significantly decreased total triiodothyronine, and total and free thyroxine concentrations compared with those which made a full recovery. Total triiodothyronine concentrations were significantly lower in dogs that were euthanased compared with those which made a partial recovery. CLINICAL SIGNIFICANCE: Thyroid hormone concentrations may be used as prognostic indicators in dogs with non-thyroidal illness. Low triiodothyronine syndrome may be more common in dogs than previously recognised.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17784933     DOI: 10.1111/j.1748-5827.2007.00418.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  9 in total

1.  Retrospective evaluation of circulating thyroid hormones in critically ill dogs with systemic inflammatory response syndrome.

Authors:  Massimo Giunti; Roberta Troia; Mara Battilani; Luciana Giardino; Francesco Dondi; Giulia Andreani; Federico Fracassi
Journal:  J Vet Sci       Date:  2017-12-31       Impact factor: 1.672

2.  An area ratio of thyroid gland to common carotid artery for evaluating the thyroid gland size.

Authors:  Noboru Sasaki; Noriyuki Nagata; Keitaro Morishita; Tatsuyuki Osuga; Kazuyoshi Sasaoka; Nozomu Yokoyama; Hiroshi Ohta; Mitsuyoshi Takiguchi
Journal:  J Vet Med Sci       Date:  2020-06-04       Impact factor: 1.267

3.  Investigation of adrenal and thyroid gland dysfunction in dogs with ultrasonographic diagnosis of gallbladder mucocele formation.

Authors:  Kathleen M Aicher; John M Cullen; Gabriela S Seiler; Katharine F Lunn; Kyle G Mathews; Jody L Gookin
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

4.  Comparison of 2 assays for measuring serum total thyroxine concentration in dogs and cats.

Authors:  Ewan D S Wolff; Graham Bilbrough; George Moore; Lynn Guptill; J Catharine Scott-Moncrieff
Journal:  J Vet Intern Med       Date:  2020-02-03       Impact factor: 3.333

5.  Physiology in conservation translocations.

Authors:  Esther Tarszisz; Christopher R Dickman; Adam J Munn
Journal:  Conserv Physiol       Date:  2014-12-17       Impact factor: 3.079

6.  Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment.

Authors:  C E Reusch; F Fracassi; N S Sieber-Ruckstuhl; W A Burkhardt; N Hofer-Inteeworn; C Schuppisser; M Stirn; R Hofmann-Lehmann; F S Boretti
Journal:  J Vet Intern Med       Date:  2017-10-11       Impact factor: 3.333

7.  Effects of Levothyroxine Administration and Withdrawal on the Hypothalamic-Pituitary-Thyroid Axis in Euthyroid Dogs.

Authors:  V Ziglioli; D L Panciera; G C Troy; W E Monroe; K M Boes; K R Refsal
Journal:  J Vet Intern Med       Date:  2017-04-22       Impact factor: 3.333

8.  Spontaneous primary hypothyroidism in 7 adult cats.

Authors:  Mark E Peterson; Marcia A Carothers; David A Gamble; Mark Rishniw
Journal:  J Vet Intern Med       Date:  2018-10-07       Impact factor: 3.333

9.  Serum thyroxine and thyrotropin concentrations decrease with severity of nonthyroidal illness in cats and predict 30-day survival outcome.

Authors:  Mark E Peterson; Danielle L Davignon; Nicole Shaw; Eric Dougherty; Mark Rishniw; John F Randolph
Journal:  J Vet Intern Med       Date:  2020-10-01       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.